Pediatric Outpatient Parenteral Antimicrobial Therapy: An Update

Advances in Pediatrics

Volumn 57, Issue 1, 2010, Pages 219-245

  Maraqa, Nizar F ^a   Rathore, Mobeen H ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b WOLFSON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

BACTERIAL INFECTION; CHILD; FEMALE; FORECASTING; HOME CARE; HUMAN; INFUSION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NURSE ATTITUDE; OUTPATIENT; PATIENT SELECTION; PRESCHOOL CHILD; REVIEW; STATISTICS; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; FEMALE; FORECASTING; HOME CARE SERVICES; HUMANS; INFUSIONS, INTRAVENOUS; INFUSIONS, PARENTERAL; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; MALE; NURSE'S ROLE; OUTPATIENTS; PATIENT SELECTION; TREATMENT OUTCOME;

EID: 78149380833     PISSN: 00653101     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.yapd.2010.09.002     Document Type: Review

References (127)

1. Tice A.D., Rehm S.J., Dalovisio J.R., et al. Practice guidelines for outpatient parenteral antimicrobial therapy. Clin Infect Dis 2004, 38:1651-1672.
2. Steinmetz D., Berkovits E., Edelstein H., et al. Home intravenous antibiotic therapy programme, 1999. J Infect 2001, 42:176-180.
3. Williams D.N., Rehm S.J., Tice A.D., et al. Practice guidelines for community-based parenteral anti-infective therapy. Clin Infect Dis 1997, 25:787-801.
4. Huminer D., Bishara J., Pitlik S. Home intravenous antibiotic therapy with infective endocarditis. Eur J Clin Microbiol Infect Dis 1999, 18:330-334.
5. Esposito S. Parenteral cephalosporin therapy in ambulatory care: advantages and disadvantages. Drugs 2000, 59(Suppl 3):19-28.
6. Tice A. Outpatient parenteral antimicrobial therapy as an alternative to hospitalization. Int J Clin Pract 1998, 95:S4-8.
7. Slavik R.S., Jewessen P.J. Selecting antibacterials for outpatient parenteral antimicrobial therapy. Pharmacokinetic and pharmacodynamic considerations. Clin Pharmacokinet 2003, 42:793-817.
8. Rucker R.W., Harrison G.M. Outpatient intravenous medications in the management of cystic fibrosis. Pediatrics 1974, 54:358-360.
9. Antoniskis A., Anderson B.C., Van Volkinburg E.J., et al. Feasibility of outpatient self-administration of parenteral antibiotics. West J Med 1978, 128:203-206.
10. Portez D.M. Evolution of outpatient parenteral antibiotic therapy. Infect Dis Clin North Am 1998, 12:827-834.
11. Brown R.B., Sands M. Outpatient intravenous antibiotic therapy. Am Fam Physician 1989, 40:157-162.
12. Leggett J.E. Ambulatory use of parenteral antibacterials: contemporary perspectives. Drugs 2000, 59(Suppl 3):1-8.
13. Stiver H.G., Telford G.O., Mossey J.M., et al. Intravenous antibiotic therapy at home. Ann Intern Med 1978, 89:690-693.
14. Gilchrist M., Franklin B.D., Patel J.P. An outpatient parenteral antibiotic therapy (OPAT) map to identify risks associated with an OPAT service. J Antimicrob Chemother 2008, 62:177-183.
15. Dalovisio J.R., Juneau J., Baumgarten K., et al. Financial impact of a home intravenous antibiotics program on a Medicare managed care program. Clin Infect Dis 2000, 30:639-642.
16. Williams D.N., Bosch D., Boots J., et al. Safety, efficacy and cost savings in an outpatient intravenous antibiotic program. Clin Ther 1993, 15:169-179.
17. Matthews P.C., Conlon C.P., Berendt A.R., et al. Outpatient parenteral antimicrobial therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years. J Antimicrob Chemother 2007, 60:356-362.
18. Goodfellow A.F., Wai A.O., Frighetto L., et al. Quality-of-life assessment in an outpatient parenteral antibiotic program. Ann Pharmacother 2002, 36:1851-1855.
19. Parker S.E., Nathwani D., O'Reilly D., et al. Evaluation of the impact of non-inpatient i.v. antibiotic treatment for acute infections on the hospital, primary care services and the patient. J Antimicrob Chemother 1998, 42:373-380.
20. Gomez M.M., Alvarez A.M., Rathore M.H. Quality of life in pediatric outpatient antibiotic therapy [abstract]. Pediatr Res 2001, 49:126.
21. Dagan R., Einhorn M. A program of outpatient parenteral antibiotic therapy for serious pediatric bacterial infections. Rev Infect Dis 1991, 13(S2):S152-S155.
22. Tice A.D. Handbook of outpatient parenteral antimicrobial therapy for infectious diseases 2006, The Curry Rockefeller Group, LLC, Tarrytown (NY).
23. Tice A.D. An office model of outpatient parenteral antibiotic therapy. Rev Infect Dis 1991, 13(S2):S184-188.
24. Tice A.D. Alternate site infusion: the physician-directed office-based model. J Intraven Nurs 1996, 19:188-193.
25. Jeejeebhoy K.N., Zohrab W.J., Langer B., et al. Total parenteral nutrition at home for 23 months, without complication, and with good rehabilitation. Gastroenterology 1973, 65:811-820.
26. Morales J.O., Von Behren L. Secondary bacterial infections in HIV-infected patients: an alternative ambulatory outpatient treatment utilizing intravenous cefotaxime. Am J Med 1994, 97(Suppl 2A):9-13.
27. Mortlock N.J., Schleis T. Outpatient parenteral antimicrobial therapy technology. Infect Dis Clin North Am 1998, 12:861-878.
28. Kunkel MJ, Tice AD, OPTIVA Study Group. Serious adverse events in outpatient parenteral antibiotic therapy: a prospective multicenter study [abstract 132]. In Program and abstracts of the 33rd Annual Meeting of the Infectious Diseases Society of America. (San Francisco), Alexandria Virginia: Infectious Diseases Society of America, 1995.
29. Gomez M., Maraqa N., Alvarez A., et al. Complications of outpatient parenteral antibiotic therapy in childhood. Pediatr Infect Dis J 2001, 20:541-543.
30. Schultz T.R., Durning S., Niewinski M., et al. A multidisciplinary approach to vascular access in children. J Spec Pediatr Nurs 2006, 11:254-256.
31. American Academy of Home Care Physicians. Home Care Credentialing Examination Information. Available at: Accessed October 22, 2009. http://www.aahcp.org/training.shtml.
32. Infusion Nurses Society Infusion nursing standards of practice. J Infus Nurs 2006, 29(Suppl 1):S1-92.
33. Infusion Nurses Certification Corporation Web Site. Available at: Accessed October 17, 2009. http://incc1.i4a.com/i4a/pages/index.cfm%3Fpageid%3D1.
34. American Society of Health-System Pharmacists ASHP guidelines on the pharmacist's role in home care. Am J Health Syst Pharm 2000, 57:1252-1257.
35. American Society of Health-System Pharmacists (ASHP) ASHP statement on the pharmacist's role with respect to drug delivery systems and administration devices. Am J Hosp Pharm 1993, 50:1724-1725.
36. Tice A.D. Bloodborne pathogen exposure and recommendations for management. J Infus Nurs 2002, 25(Suppl 6):S5-9.
37. Kaley J., Berendt A.R., Snelling M.J., et al. Safe intravenous antibiotic therapy at home: experience of a UK based programme. J Antimicrob Chemother 1996, 37:1023-1029.
38. Nolet B.R. Patient selection in outpatient antimicrobial therapy. Infect Dis Clin North Am 1998, 12:835-847.
39. Brown R.B. Selection and training of patients for outpatient intravenous antibiotic therapy. Rev Infect Dis 1991, 13(Suppl 2):S147-S151.
40. Chung M., Akahoshi M. Reducing home nursing visit costs using a remote access infusion pump system. J Intraven Nurs 1999, 22:309-314.
41. DeMaio J., Schwartz L., Cooley P., et al. The application of telemedicine technology to a directly observed therapy program for tuberculosis: a pilot project. Clin Infect Dis 2001, 33:2082-2084.
42. Maraqa N., Gomez M., Rathore M.H. Outpatient parenteral antimicrobial therapy in osteoarticular infections in children. J Pediatr Orthop 2002, 22:506-510.
43. Goldenberg R.I., Portez D.M., Eron L.J., et al. Intravenous antibiotic therapy in ambulatory pediatric patients. Pediatr Infect Dis 1984, 3:514-517.
44. Gutierrez K. Continuation of antibiotic therapy for serious bacterial infections outside of the hospital. Pediatr Ann 1996, 25:639-645.
45. Leaver J., Radivan F., Patel L., et al. Home intravenous antibiotic therapy: practical aspects in children. J R Soc Med 1997, 90(Suppl 31):26-33.
46. Kinsey S.E. Experience with teicoplanin in non-inpatient therapy in children with central line infections. Eur J Haematol 1998, 62:S11-14.
47. Shemesh E., Yaniv I., Drucker M., et al. Home intravenous antibiotic treatment for febrile episodes in immune-compromised pediatric patients. Med Pediatr Oncol 1998, 30:95-100.
48. Dagan R., Fliss D.M., Einhorn M., et al. Outpatient management of chronic suppurative otitis media without cholesteatoma in children. Pediatr Infect Dis J 1992, 11:542-546.
49. Bradley J.S., Ching D.K., Phillips S.E. Outpatient therapy of serious pediatric infections with ceftriaxone. Pediatr Infect Dis J 1988, 7:160-164.
50. Gilbert J., Robinson T., Littlewood J.M. Home intravenous antibiotic treatment in cystic fibrosis. Pediatr Pulmonol 1988, 4:84-89.
51. Esposito S., Leone S., Noviello S., et al. Outpatient parenteral antibiotic therapy for bone and joint infections: an Italian multicenter study. J Chemother 2007, 19:417-422.
52. Zaoutis T., Localio A.R., Leckerman K., et al. Prolonged intravenous therapy versus early transition to oral antimicrobial therapy for acute osteomyelitis in children. Pediatrics 2009, 123:636-642.
53. Weichert S., Sharland M., Clarke N.M., et al. Acute Hematogenous osteomyelitis in children: is there any evidence for how ling we should treat?. Curr Opin Infect Dis 2008, 21:258-262.
54. Bachur R., Pagon Z. Success of short-course parenteral antibiotic therapy for acute osteomyelitis of childhood. Clin Pediatr (Phila) 2007, 46:30-35.
55. Faden D., Faden H.S. The high rate of adverse drug events in children receiving prolonged outpatient antibiotic therapy for osteomyelitis. Pediatr Infect Dis J 2009, 28:539-541.
56. Bradley J.S. What is the appropriate treatment course for bacterial arthritis in children?. Clin Infect Dis 2009, 48:1211-1212.
57. Hawkshead J.J., Patel N.B., Steele R.W., et al. Comparative severity of pediatric osteomyelitis attributable to methicillin-resistant versus methicillin-sensitive Staphylococcus aureus. J Pediatr Orthop 2009, 29:85-90.
58. Deery H. Outpatient parenteral anti-infective therapy for skin and soft-tissue infections. Infect Dis Clin North Am 1998, 12:935-949.
59. Chapman A.L., Dixon S., Andrews D., et al. Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective. J Antimicrob Chemother 2009, 64:1316-1324.
60. Chary A., Tice A.D., Martinelli L.P., et al. Experience of infectious diseases consultants with outpatient antimicrobial therapy: results of an Emerging Infections Network survey. Clin Infect Dis 2006, 43:1290-1295.
61. Gerber J.S., Coffin S.E., Smathers S.A., et al. Trends in incidence of methicillin-resistant Staphylococcus aureus in children's hospitals in the United States. Clin Infect Dis 2009, 49:65-71.
62. Johnson P.N., Rapp R.P., Nelson C.T., et al. Characterization of community-acquired Staphylococcus aureus infections in children. Ann Pharmacother 2007, 41:1361-1367.
63. Gilchrist F.J., Lenney W. A review of the home intravenous antibiotic service available to children with cystic fibrosis. Arch Dis Child 2009, 94:647.
64. Balaguer A., González de Dios J. Home antibiotic therapy for cystic fibrosis. Cochrane Database Syst Rev 2008, 16. CD001917.
65. Termoz A., Touzet S., Bourdy S., et al. Effectiveness of home treatment for patients with cystic fibrosis: the intravenous administration of antibiotics to treat respiratory infections. Pediatr Pulmonol 2008, 43:908-915.
66. Horvais V., Touzet S., Francois S., et al. Cost of home and hospital care for patients with cystic fibrosis followed up in two reference medical centers in France. Int J Technol Assess Health Care 2006, 22:525-531.
67. Nazer D., Abdulhamid I., Thomas R., et al. Home versus hospital intravenous antibiotic therapy for acute pulmonary exacerbations in children with cystic fibrosis. Pediatr Pulmonol 2006, 41:744-749.
68. Bradley J.S. Outpatient parenteral antibiotic therapy: management of serious infections. Part 1: Medical socioeconomic, and legal issues: pediatric considerations. Hosp Pract (Off Ed) 1993, 28(Suppl 1):28-32.
69. Proesmans M., DeBoeck K. Clinical Practice: treatment of childhood empyema. Eur J Pediatr 2009, 168:639-645.
70. Dimayuga E., Brown R.B. Outpatient parenteral antibiotic therapy for infective endocarditis. Infect Dis Clin Pract 1995, 4:468-471.
71. Andrews M.M., Reyn C.F. Patient selection criteria and management guidelines for outpatient parenteral antibiotic therapy for native valve infective endocarditis. Clin Infect Dis 2001, 33:203-209.
72. Rehm S.J. Outpatient intravenous antibiotic therapy for infective endocarditis. Infect Dis Clin North Am 1998, 12:879-901.
73. Larioza J., Heung L., Girard A., et al. Management of infective endocarditis in outpatients: clinical experience with outpatient parenteral antibiotic therapy. South Med J 2009, 102:575-579.
74. Gauthier M., Chevalier I., Sterescu A., et al. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center. Pediatrics 2004, 114:e469-e476.
75. Zorc J.J., Kiddoo D.A., Shaw K.N. Diagnosis and management of pediatric urinary tract infections. Clin Microbiol Rev 2005, 18:417-422.
76. Committee on Infectious Diseases American Academy of Pediatrics. Treatment of bacterial meningitis. Pediatrics 1988, 81:904-907.
77. McCracken G.H., Nelson J.D., Kaplan S.L., et al. Consensus report: antimicrobial therapy for bacterial meningitis in infants and children. Pediatr Infect Dis J 1987, 6:501-505.
78. Kaplan S.L. Serious pediatric infections. Am J Med 1990, 88:185-245.
79. Bradley J.S. Outpatient antibiotic therapy. Management of serious infections. Part II: amenable infections and models of delivery. Meningitis. Hosp Pract (Off Ed) 1993, 28(Suppl 2):15-19.
80. Waler J.A., Rathore M.H. Outpatient management of pediatric bacterial meningitis. Pediatr Infect Dis J 1995, 14:89-92.
81. Gilbert D.N., Dworkin R.J., Raber S.R., et al. Outpatient parenteral antimicrobial-drug therapy. N Engl J Med 1997, 337:829-838.
82. Neftel K.A. Effect of storage of penicillin-G solutions on sensitization to penicillin-G after intravenous administration. Lancet 1982, 1:986-988.
83. O'Sullivan T.L., Ruffing M.J., Lamp K.C., et al. Prospective evaluation of red man syndrome in patients receiving vancomycin. J Infect Dis 1993, 168:773-776.
84. Maraqa N.F., Gomez M.M., Rathore M.H., et al. Higher occurrence of hepatotoxicity and rash in patients treated with oxacillin compared to those treated with nafcillin and other commonly used antibiotics. Clin Infect Dis 2002, 34:50-54.
85. Bhatt-Mehta V., Schumacher R.E., Faix R.G., et al. Lack of vancomycin-associated nephrotoxicity in newborn infants: a case control study. Pediatrics 1999, 103:e48.
86. Sorrell T.C., Collignon P.J. A prospective study of adverse reactions associated with vancomycin therapy. J Antimicrob Chemother 1985, 16:235-241.
87. Palmer-Toy D.E. Therapeutic monitoring of vancomycin. Arch Pathol Lab Med 2000, 124:322-323.
88. James C.W., Guk-Turner C. Recommendations for monitoring serum vancomycin concentrations. Proc (Bayl Univ Med Cent) 2001, 14:189-190.
89. Kahyaoglu O., Akpinar M., Nolan B., et al. Vancomycin use and monitoring in pediatric patients in a community hospital. Infect Control Hosp Epidemiol 1998, 19:299-301.
90. Lau C. Transparent and gauze dressings and their effect on infection rates of central venous catheters: a review of past and current literature. J Intraven Nurs 1996, 19:240-245.
91. Pugliese G. Reducing risks of infection during vascular access. J Intraven Nurs 1997, 20(Suppl 6):S11-S23.
92. Russell P.B., Kline J., Yoder M.C., et al. Staphylococcal adherence to polyvinyl chloride and heparin-bonded polyurethane catheters is species dependant and enhanced by fibronectin. J Clin Microbiol 1987, 25:1083-1087.
93. Schleis T.G., Tice A.D. Selecting infusion devices for use in ambulatory care. Am J Health Syst Pharm 1996, 53:868-877.
94. Kravitz G.R. Outpatient parenteral antibiotic therapy: management of serious infections. Part 1: Medical socioeconomic, and legal issues: advances in i.v. delivery. Hosp Pract (Off Ed) 1993, 28(Suppl 1):21-27.
95. LaRue G.D. Improving central placement rates of peripherally inserted catheters. J Intraven Nurs 1995, 18:24-27.
96. Hussain S., Gomez M., Wludyka P., et al. Survival times and complications of catheters used for outpatient parenteral antibiotic therapy in children. Clin Pediatr (Phila) 2007, 46:247-251.
97. Ruebner R., Karen R., Coffin S., et al. Complications of central venous catheters used for the treatment of acute hematogenous osteomyelitis. Pediatrics 2006, 117:1210-1215.
98. Gorski L.A. The peripheral intravenous catheter: an appropriate yet often overlooked choice for venous access. Home Healthc Nurse 2009, 27:130-132.
99. Goodwin M., Carlson I. The peripherally inserted central catheter. J Intraven Nurs 1993, 16:92-103.
100. Wall J.L., Keirstead V. Peripherally inserted central catheters. J Intraven Nurs 1995, 18:251-255.
101. Van Winkle P., Whiffen T., Liu I. Experience using peripherally inserted central venous catheters for outpatient parenteral antibiotic therapy in children at a community hospital. Pediatr Infect Dis J 2008, 27:1069-1072.
102. ®. BARD Access Systems, Inc.Salt Lake City (UT) Avilable at:, Accessed October 20, 2009. http://www.bardaccess.com/powerpicc//front.php.
103. Knue M., Doellman D., Rabin K., et al. The efficacy and safety of blood sampling though peripherally inserted central catheter devices in children. J Infus Nurs 2005, 28:30-35.
104. Kaufman J. The interventional radiologist's role in providing and maintaining long-term central venous access. J Intraven Nurs 2001, 24:S23-S27.
105. Ng P.K., Ault M.J., Ellrodt A.G., et al. Peripherally inserted central catheters in general medicine. Mayo Clin Proc 1997, 72:225-233.
106. Finney R., Albrink M.H., Hart M.G., et al. A cost-effective peripheral venous port system placed at the bedside. J Surg Res 1992, 53:17-19.
107. Stovroff M.C., Totten M., Glick P.L. PIC lines save money and hasten discharge in the care of children with ruptured appendicitis. J Pediatr Surg 1994, 29:245-247.
108. Thiagarajan R., Ramamoorthy C., Gettman T., et al. Survey of the use of peripherally inserted central venous catheters in children. Pediatrics 1997, 99:e4.
109. Frey A. Pediatric peripherally inserted central catheter program report: a summary of 4536 catheter days. J Intraven Nurs 1995, 18:280-291.
110. O'Grady N.P., Alexander M., Dellinger E.P., et al. Guidelines for the prevention of intravascular catheter-related infections. Center for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 2002, 51(RR-10):1-29.
111. Jackson D. Infection control principles and practices in the care and management of vascular access devices in the alternate care setting. J Intraven Nurs 2001, 24:S28-S34.
112. Siegel J.D., Rhinehart E., Jackson M., et al. and the Healthcare Infection Control Practices Advisory Committee. Guideline for isolation precautions: preventing transmission of infectious agents in healthcare settings Avilable at:, Accessed September 21, 2010. http://www.cdc.gov/hicpac/pdf/isolation/Isolation2007.pdf.
113. Occupational Safety and Health Administration. Revised Bloodborne Pathogens Standard Avilable at:, Accessed October 20, 2009. http://www.osha.gov/SLTC/bloodbornepathogens/standards.html.
114. Mermel L.A., Farr B.M., Sheretz R.J., et al. Guidelines for the management of intravascular catheter-related infections. J Intraven Nurs 2001, 24:180-205.
115. Tice A.D. The team concept. Hosp Pract 1993, 28(Suppl 1):6-10.
116. Kaye T. Prolonged infusion times with disposable elastomeric infusion devices. Am J Hosp Pharm 1994, 51:533-534.
117. Rich D.S. Evaluation of a disposable, elastomeric infusion device in the home environment. Am J Hosp Pharm 1992, 49:1712-1716.
118. Coley S.C., Shaw P.K., Leff R.D. Performance of three portable infusion-pump devices set to deliver 2 ml/hr. Am J Health Syst Pharm 1997, 54:1277-1280.
119. Veal D.F., Altman C.E., McKinnon B.T., et al. Evaluation of flow rates for six disposable infusion devices. Am J Health Syst Pharm 1995, 52:500-504.
120. Ingram P.R., Sulaiman Z., Chua A., et al. Comment on: outpatient parenteral antibiotic therapy (OPAT): is it safe for selected patients to self-administer at home? A retrospective analysis of a large cohort over 13 years. J Antimicrob Chemother 2008, 61:226-227.
121. Kwan V. High-technology IV infusion devices. Am J Hosp Pharm 1989, 46:320-335.
122. New P.B., Swanson G.F., Bulich R.G., et al. Ambulatory antibiotic infusion devices: extending the spectrum of outpatient therapies. Am J Med 1991, 91:455-461.
123. Rich D. Physicians, pharmacists, and home infusion antibiotic therapy. Am J Med 1994, 97(Suppl 1):3-8.
124. Kappeler K.H., Bridwell S.W., Scheckelhoff D.J., et al. Model for evaluating costs associated with i.v. drug delivery systems. Am J Health Syst Pharm 1993, 49:1478-1481.
125. Kunkel M.J. Quality assurance and outcomes in outpatient parenteral antibiotic therapy. Infect Dis Clin North Am 1998, 12:1023-1034.
126. Joint Commission 2009 Comprehensive Accreditation Manual for Home Care (CAMHC) Avilable at:, Accessed October 19, 2009. http://www.jcrinc.com/Accreditation-Manuals/2009-CAMHC/1324/.
127. Nathwani D., Tice A.D. Ambulatory antimicrobial use: the value of an outcomes registry. J Antimicrob Chemother 2002, 49:149-154.